FDA awards Castle Creek $1.8M grant for late-stage testing of gene therapy for 'butterfly children'
October 25, 2021 at 14:22 PM EDT
The company's gene therapy is being developed to treat a rare disease that causes skin to easily blister from any type of friction.
